Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1935 4
1936 2
1937 5
1938 3
1939 1
1941 2
1942 3
1943 5
1944 3
1945 3
1946 9
1947 17
1948 11
1949 11
1950 13
1951 12
1952 7
1953 6
1954 8
1955 5
1956 5
1957 2
1958 2
1959 2
1960 2
1961 4
1962 11
1963 13
1964 13
1965 12
1966 5
1968 4
1970 2
1971 1
1972 2
1973 5
1974 4
1975 6
1976 2
1977 2
1978 6
1979 1
1981 1
1982 2
1983 1
1985 1
1987 1
1988 1
1989 2
1990 2
1991 3
1992 6
1993 4
1994 2
1995 2
1996 2
1997 1
1998 1
1999 3
2000 1
2001 2
2002 5
2003 4
2004 11
2005 15
2006 15
2007 12
2008 24
2009 19
2010 17
2011 26
2012 14
2013 23
2014 24
2015 34
2016 27
2017 26
2018 21
2019 29
2020 30
2021 49
2022 40
2023 37
2024 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

763 results

Results by year

Filters applied: . Clear all
Page 1
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.
Pilette C, Canonica GW, Chaudhuri R, Chupp G, Lee FE, Lee JK, Almonacid C, Welte T, Alfonso-Cristancho R, Jakes RW, Maxwell A, Price RG, Howarth P. Pilette C, et al. Among authors: chaudhuri r. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2646-2656. doi: 10.1016/j.jaip.2022.05.042. Epub 2022 Jun 24. J Allergy Clin Immunol Pract. 2022. PMID: 35753668 Free article.
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Khaleva E, Rattu A, Brightling C, Bush A, Bossios A, Bourdin A, Chung KF, Chaudhuri R, Coleman C, Dahlén SE, Djukanovic R, Deschildre A, Fleming L, Fowler SJ, Gupta A, Hamelmann E, Hashimoto S, Hedlin G, Koppelman GH, Melén E, Murray CS, Pilette C, Porsbjerg C, Pike KC, Rusconi F, Williams C, Ahrens B, Alter P, Anckers F, van den Berge M, Blumchen K, Brusselle G, Clarke GW, Cunoosamy D, Dahlén B, Dixey P, Exley A, Frey U, Gaillard EA, Giovannini-Chami L, Grigg J, Hartenstein D, Heaney LG, Karadag B, Kaul S, Kull I, Licari A, Maitland-van der Zee AH, Mahler V, Schoos AM, Nagakumar P, Negus J, Nielsen H, Paton J, Pijnenburg M, Ramiconi V, Romagosa Vilarnau S, Principe S, Rutjes N, Saglani S, Seddon P, Singer F, Staudinger H, Turner S, Vijverberg S, Winders T, Yasinska V, Roberts G; COMSA Working Group in the 3TR Consortium. Khaleva E, et al. Among authors: chaudhuri r. Eur Respir J. 2023 Apr 3;61(4):2200606. doi: 10.1183/13993003.00606-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36229046 Free PMC article. Review.
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
Devereux G, Cotton S, Nath M, McMeekin N, Campbell K, Chaudhuri R, Choudhury G, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, MacLennan G, Morice A, Norrie J, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Wu O, Lipworth BJ. Devereux G, et al. Among authors: chaudhuri r. JAMA. 2024 Aug 13;332(6):462-470. doi: 10.1001/jama.2024.8771. JAMA. 2024. PMID: 38762800 Free PMC article. Clinical Trial.
Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry.
McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, Mansur A, Patel M, Burhan H, Doe S, Chaudhuri R, Gore R, Dodd JW, Subramanian D, Brown T, Heaney LG; UK Severe Asthma Registry. McDowell PJ, et al. Among authors: chaudhuri r. Eur Respir J. 2023 Dec 14;62(6):2300819. doi: 10.1183/13993003.00819-2023. Print 2023 Dec. Eur Respir J. 2023. PMID: 37857423 Free PMC article.
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.
Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T. Vijiaratnam N, et al. Among authors: chaudhuri r. BMJ Open. 2021 May 28;11(5):e047993. doi: 10.1136/bmjopen-2020-047993. BMJ Open. 2021. PMID: 34049922 Free PMC article.
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
Cotton S, Devereux G, Abbas H, Briggs A, Campbell K, Chaudhuri R, Choudhury G, Dawson D, De Soyza A, Fielding S, Gompertz S, Haughney J, Lang CC, Lee AJ, MacLennan G, MacNee W, McCormack K, McMeekin N, Mills NL, Morice A, Norrie J, Petrie MC, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Lipworth BJ. Cotton S, et al. Among authors: chaudhuri r. Trials. 2022 Apr 14;23(1):307. doi: 10.1186/s13063-022-06226-8. Trials. 2022. PMID: 35422024 Free PMC article. Clinical Trial.
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). McDowell PJ, et al. Among authors: chaudhuri r. Lancet Respir Med. 2021 Oct;9(10):1174-1184. doi: 10.1016/S2213-2600(21)00004-7. Epub 2021 May 7. Lancet Respir Med. 2021. PMID: 33971168
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control.
Zeng X, Qing J, Li CM, Lu J, Yamawaki T, Hsu YH, Vander Lugt B, Hsu H, Busby J, McDowell PJ, Jackson DJ, Djukanovic R, Matthews JG, Arron JR, Bradding P, Brightling CE, Chaudhuri R, Choy DF, Cowan D, Fowler SJ, Hardman TC, Harrison T, Howarth P, Lordan J, Mansur AH, Menzies-Gow A, Pavord ID, Walker S, Woodcock A, Heaney LG; investigators for the UK MRC Refractory Asthma Stratification Program (RASP-UK). Zeng X, et al. Among authors: chaudhuri r. J Allergy Clin Immunol. 2023 Oct;152(4):876-886. doi: 10.1016/j.jaci.2023.05.023. Epub 2023 Jun 12. J Allergy Clin Immunol. 2023. PMID: 37315813 Free article. Clinical Trial.
Identifying and appraising outcome measures for severe asthma: a systematic review.
Rattu A, Khaleva E, Brightling C, Dahlén SE, Bossios A, Fleming L, Chung KF, Melén E, Djukanovic R, Chaudhuri R, Exley A, Koppelman GH, Bourdin A, Rusconi F, Porsbjerg C, Coleman C, Williams C, Nielsen H, Davin E, Taverner P, Romagosa Vilarnau S, Roberts G; 3TR Consortium Respiratory Work Package. Rattu A, et al. Among authors: chaudhuri r. Eur Respir J. 2023 Apr 3;61(4):2201231. doi: 10.1183/13993003.01231-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36549712 Free article. Review.
Pain in Multiple System Atrophy a Systematic Review and Meta-Analysis.
Campese N, Caliò B, Leys F, Kaltenbach L, Göbel G, Wanschitz J, Schlager A, Zamarian L, Bannister K, Chaudhuri RK, Schrag A, Granata R, Kiechl S, Poewe W, Seppi K, Wenning G, Fanciulli A. Campese N, et al. Among authors: chaudhuri rk. Mov Disord Clin Pract. 2023 Oct 18;10(12):1738-1749. doi: 10.1002/mdc3.13897. eCollection 2023 Dec. Mov Disord Clin Pract. 2023. PMID: 38094640 Free PMC article. Review.
763 results